Spectral Medical Inc. (TSE:EDT - Get Free Report) shares reached a new 52-week high during trading on Wednesday . The company traded as high as C$0.88 and last traded at C$0.86, with a volume of 26500 shares trading hands. The stock had previously closed at C$0.85.
Spectral Medical Stock Performance
The firm has a market cap of C$247.50 million, a P/E ratio of -12.57 and a beta of 0.96. The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. The stock has a 50 day moving average of C$0.81 and a 200 day moving average of C$0.68.
About Spectral Medical
(
Get Free Report)
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Featured Stories
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
